Navigation Links
Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures
Date:11/5/2008

-- Online survey shows people living with epilepsy often miss a dose of their antiepileptic drug

-- UCB continues to build on the company's commitment to patients living with epilepsy through the launch of Keppra XR(TM) (levetiracetam) extended-release tablets

-- Keppra XR(TM) is one of many upcoming milestones in the UCB Epilepsy Franchise

ATLANTA, Nov. 5 /PRNewswire/ -- press release, regulated information: UCB announced today that Keppra XR(TM) offers convenient dosing for people with epilepsy. Keppra XR(TM) was approved by the U.S. Food and Drug Administration (FDA) in September 2008 for use as an add-on to other antiepileptic treatments for people with partial-onset seizures who are 16 years of age and older.

While many people with epilepsy are successfully treated with one or more of the currently available antiepileptic drugs, a significant percentage still live with uncontrolled seizures or intolerable side effects.

A recent online survey of 451 people living with epilepsy showed that almost half missed at least one dose of their epilepsy medication in the last month, and 37 percent who missed a dose reported having a breakthrough seizure. More than 80 percent of these people missed a dose of an antiepileptic drug (AED) that was taken multiple times daily and the most common reason reported for having missed a dose was forgetfulness. The survey was conducted by UCB.

Keppra XR(TM) offers once-daily dosing and is made specifically for epilepsy. Keppra XR(TM) is the only extended-release formulation of levetiracetam, and there is no generic version available.

UCB - The Epilepsy Company(TM)

"The launch of Keppra XR(TM) is the first of many upcoming milestones for UCB's epilepsy franchise," said Rich Denness, vice president & general manager, CNS, UCB. "At UCB, we are committed to developing innovative treatments for epilepsy and improving the lives of people and their families living with this condit
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
2. Health care incentive model offers collaborative approach
3. Eye-staining technique offers early detection for dry eye syndrome
4. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
5. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
6. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
7. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
8. Regence Offers InterM to Fill Gap for the Uninsured
9. National Non-Profit Organization Offers Free Mental Health Services to Military and Military Families
10. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
11. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Nov. 30 A new study has found th...care insurance customers have a current intention ...erage. The figure is up from 20% in 2008. Over t...ure has been a leading indicator of actual switchi...ion to switch actually will leave their current in...
(Date:11/30/2009)...o more women having babies later in life, , ...wing number of children in the United States are b...say. , The overriding reason, experts add, is t...from 10 regional registries of birth defects show ...ldren increased by 31 percent between 1979 and 200...
(Date:11/30/2009)... ShowMyPC has released an online service that let...where. This is the first hosted service in the wor...op program. Result, blazing fast performance even ... Santa Clara, CA (PRWEB) November 30, 2009 -- Sho... Access Service that uses the familiar Microsoft R...
(Date:11/30/2009)... Lawyers from The Healy Law Firm secure the highe...half of man rendered an incomplete quadriplegic. ...) November 30, 2009 -- A Cook County jury has ente...mmigrant carpenter, 22 years old at the time, who ...mplete quadriplegic. The verdict, which was reduc...
(Date:11/30/2009).... 30 Three decades ago, a study re...lowed by children, prompting a switch by U.S. manu...y at the annual meeting of the Radiological Societ...are still potentially unsafe. ,, "One of the dr...onstruction in the U.S. was to eliminate inadverte...
Breaking Medicine News(10 mins):Health News:More Seniors Considering Health Insurance Switch 2Health News:U.S. Records Increase in Kids With Down Syndrome 2Health News:U.S. Records Increase in Kids With Down Syndrome 3Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 2Health News:Cook County Jury Awards a Gross Verdict of $8.1 Million to Victim of Swimming Pool Accident 3Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2
...erior cervical plating system offers zero-step loc... Life Spine announces the nationwide market introd... Plating System. KINETIC-SL, which gained 510(k) ... zero-step locking mechanism allowing bone screws ...
...e/ -- Cylene Pharmaceuticals, Inc., announced to...elopment of their first-in-class, CK2 inhibitor CX...Wednesday, May 20th at 4:40 pm. William G. Rice, P... inhibitor currently in Phase I clinical trials. ...
...vidly the core message of HealthCorps, fight again...ng "Not Just DNA" was successfully auctioned at Th...thCorps, Founder and Chairman, and his wife Lisa O... commented, "Dahiya,s painting, ,Not Just DNA, is ...
...25, 2009 , , CytoFlora decreases IgA and IgM a...immune disorders and autism. , , LAGUNA HILLS, ... of autistic children are affected by gastrointest...thogens out of the gastrointestinal tract and assi...
...on to offer the online social network the chance t...essionals who weigh in at the site, topics of inte...ered , , NEW YORK, May 19 FertilityTies ( www....se of accredited MDs, will bridge the divide betwe...
...hrenia is one of the most disabling diseases,(1) a...sult of the disease place enormous burdens on pati...new studies, the use of RISPERDAL(R) CONSTA(R) (ri...hrenia. Results of the studies were presented this...
Other Medicine News:Health News:Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference 2Health News:Artist Neera Dahiya Featured at Silent Auction Held During HealthCorps' Green Garden Gala 2Health News:Artist Neera Dahiya Featured at Silent Auction Held During HealthCorps' Green Garden Gala 3Health News:BioRay's CytoFlora Reduces Digestive and Behavioral Issues in Autistic Children 2Health News:FertilityTies.com Convention Open to the Public, June 6, 1-5 PM at The Hilton New York Hotel, MDs to Lead Discussion on Timely Fertility Topics 2Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 2Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 3Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 4Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 5Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 6Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 7Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 8Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 9Health News:New Data Demonstrate RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment May Improve Health Outcomes and Reduce Hospitalizations in Patients with Schizophrenia 10
(Date:11/29/2009)...IS, Nov. 29 VIDA Diagnostics, a le...or the advanced analysis of pulmonary diseases, an...y invasive delivery of interventional oncology the...nitive agreement covering joint development and di... biopsy system. ,, "Veran,s innovative instrum...
(Date:11/29/2009)...-- This year at the Radiological Society of North ...ing, FUJIFILM Medical Systems USA is announcing it...ith the introduction of Synapse(TM) 3D*. Fujifilm...ing by now offering its own advanced imaging capab...scular applications. The company has also made ot...
(Date:11/27/2009)...Newswire-FirstCall/ -- Booth - 3646/South Hall A -...emier supplier of X-ray tubes and flat panel digit... detectors at the RSNA Annual Meeting in Chicago, ...will also be exhibiting X-ray tube technology for ...treatment technologies. ,, Varian,s exhibit wi...
Breaking Medicine Technology:VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4FUJIFILM Enters Advanced Visualization Market 2FUJIFILM Enters Advanced Visualization Market 3FUJIFILM Enters Advanced Visualization Market 4Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Help for climate stressed corals 8886 1Help for climate stressed corals 8886 2Help for climate stressed corals 8886 3The power of prayer 3F 49285 1The power of prayer 3F 49285 2Loan Repayment Legislation Includes Physical Therapists as Frontline Providers 49280 1Loan Repayment Legislation Includes Physical Therapists as Frontline Providers 49280 2
...t 9th International Symposium on,Myelodysplastic S...- New updated results,from a pivotal Phase II tria...e blood cancer known as myelodysplastic syndromes ...the H. Lee Moffitt,Cancer Center & Research In... currently taking place in Florence, Italy.,Breakt...
...7 /PRNewswire-FirstCall/ -- Vanda,Pharmaceuticals ...ters on iloperidone at the 160th American Psychiat... held at the San,Diego Convention Center in San Di...ollowing posters will be presented on May 22, 2007...ion Center (Sails,Pavilion, Upper Level). , POSTER...
Other Medicine Technology:Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting 2
...ugh continuous low-flow nebulizer performance. Pat...logy allows for optimal medication and Heliox deli...on severe asthma, COPD and pneumonia in both routi...mask, mouth and T-piece to deliver high-output, lo...
...oping diverse medical products for more than 58 ye...outstanding reputation for innovation, quality and...lly recognized brands include the Labtron® lin...undry products, Bristoline® microscopes, Healt...
...nhalers., ,ACE ensures prompt, effective delivery... versatile design allows it to be used in a ventil...airway or resuscitation bag and for routine, oral ...th an incentive spirometer to help teach the patie...
CK1001 Small Volume Medication Kits
Medicine Products: